United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 7,540 shares of the stock in a transaction that occurred on Thursday, November 5th. The stock was sold at an average price of $573.89, for a total value of $4,327,130.60. Following the completion of the sale, the chief executive officer directly owned 326,403 […]

United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 7,777 shares of United Therapeutics stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $599.64, for a total value of $4,663,400.28. Following the sale, the chief executive officer directly owned 326,166 shares of the company’s […]

What happened United Therapeutics Corp (NASDAQ: UTHR) Chairperson and CEO Martine A. Rothblatt sold 9,500 shares on Oct. 29 for about $5.65 million. The shares came from stock options exercised the same day at $117.76 each. The options vested in equal installments on March 15 of 2021, 2022 and 2023. The sales were reported at […]

What happened United Therapeutics Corp (NASDAQ: UTHR) said Martine A. Rothblatt sold 9,500 shares on 2026-10-22. Rothblatt is the chairperson, CEO and a director. The filing says the shares came from stock options exercised the same day and were sold under a Rule 10b5-1 trading plan. The options had a $117.76 exercise price. The shares […]